UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031228
Receipt number R000035662
Scientific Title Multicenter Prospective registration research for pain relief after EUS-guided neurolysis in patients suffering from upper abdominal cancer pain caused by pancreatic cancer
Date of disclosure of the study information 2018/02/09
Last modified on 2023/08/15 13:50:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multicenter Prospective registration research for pain relief after EUS-guided neurolysis in patients suffering from upper abdominal cancer pain caused by pancreatic cancer

Acronym

Multicenter Prospective registration research for EUS-guided neurolysis

Scientific Title

Multicenter Prospective registration research for pain relief after EUS-guided neurolysis in patients suffering from upper abdominal cancer pain caused by pancreatic cancer

Scientific Title:Acronym

Multicenter Prospective registration research for EUS-guided neurolysis

Region

Japan


Condition

Condition

Pancreatic cancer

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the utility of EUS-guided neurolysis in patients suffering from upper abdominal cancer pain caused by pancreatic cancer in multicenter prospective registration research.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Efficacy one week after the procedure

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Over 20-year-old
2. Patients with pancreatic cancer
3. Patients with NRS score more than 3
4. PS0-2
5. Patients without severe complication
6. Acquisition of informed consent

Key exclusion criteria

1. Patients with high-risk of bleeding
2. Difficulty of performing EUS

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Ken
Middle name
Last name Kamata

Organization

Kindai University Faculty of Medicine

Division name

Department of Gastroenterology and Hepatology

Zip code

589-8511

Address

377-2, Ohno-Higashi, Osaka-Sayama, Osaka, Japan

TEL

072-366-0221

Email

ky11@leto.eonet.ne.jp


Public contact

Name of contact person

1st name Ken
Middle name
Last name Kamata

Organization

Kindai University Faculty of Medicine

Division name

Department of Gastroenterology and Hepatology

Zip code

589-8511

Address

377-2, Ohno-Higashi, Osaka-Sayama, Osaka, Japan

TEL

072-366-0221

Homepage URL


Email

ky11@leto.eonet.ne.jp


Sponsor or person

Institute

Kindai University Faculty of Medicine

Institute

Department

Personal name



Funding Source

Organization

Kindai University Faculty of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kindai University Faculty of Medicine

Address

377-2, Ohno-Higashi, Osaka-Sayama, Osaka

Tel

0723660221

Email

ky11@leto.eonet.ne.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 02 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2017 Year 11 Month 11 Day

Date of IRB

2018 Year 02 Month 01 Day

Anticipated trial start date

2018 Year 02 Month 09 Day

Last follow-up date

2023 Year 08 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The efficacy one week after the procedure is evaluated as the primary endpoint.


Management information

Registered date

2018 Year 02 Month 09 Day

Last modified on

2023 Year 08 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035662


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name